Calamos Advisors LLC Moderna, Inc. Transaction History

Calamos Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 01, 2022	BUY	$117.13 - $176.59 $254,054 - $383,023	2,169 Added 2.77%	80,521 $11.5 Million
Q1 2022 May 03, 2022	BUY	$126.46 - $235.05 $1.32 Million - $2.45 Million	10,443 Added 15.38%	78,352 $13.5 Million
Q4 2021 Feb 01, 2022	BUY	$225.82 - $368.51 $15.3 Million - $25 Million	67,909 New	67,909 $17.2 Million
Q3 2020 Oct 26, 2020	SELL	$54.34 - $94.85 $563,179 - $983,025	-10,364 Closed	0 $0
Q2 2020 Jul 27, 2020	BUY	$29.67 - $80.0 $307,499 - $829,120	10,364 New	10,364 $665,000

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Calamos Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Calamos Advisors LLC with notifications on news.